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THERATIONALE FORHIGHERDOSE LEVOFLOXACIN
IN THE SERIOUSLY COMPROMISED HOST
Kahn JB*, Davis ND; Ortho-McNeil Pharmaceutical,
Inc.
BACKGROUND/OBJECTIVE: Advances in cancer
chemotherapy and supportive care continue to
be associated with improved survival rates and
better patient quality of life. One unwelcome
consequence of these developments, however,
is an increased vulnerability to serious, often
life-threatening infection. Many of them are due
to traditional pathogens that have acquired resis-
tance to multiple antimicrobial agents; others are
caused by commensals and relatively avirulent or-
ganisms. Current antibacterial offerings are under
stress and there are few new agents on the horizon.
One bedrock strategy for dealing with this threat
remains combination therapy; another approach,
one that has received insufﬁcient attention, is to
maximize the utility of each of our antibacterial
drugs by dosing them more rationally. The purpose
of this paper is to summarize the rationale for uti-
lizing higher doses of levoﬂoxacin in the manage-
ment of immunocompromised hosts with serious
infections.
METHODS: We have reviewed and will report on all
available microbiologic, pharmacokinetic, pharma-
codynamic, clinical efﬁcacy, and safety data from
subjects and patients exposed to daily levoﬂoxacin
doses of 750mgms or more.
RESULTS: Even after more than seven years of ex-
tensive use in the US, levoﬂoxacin has maintained
its excellent susceptibility proﬁle. Drug levels seen
in infected patients are signiﬁcantly higher than
those achieved in healthy volunteers and enable
coverage of organisms with higher MICs. Because
of its concentration-dependent bactericidal activ-
ity, higher doses of levoﬂoxacin increase the speed
and thoroughness of bacterial eradication in vitro
and can inhibit the emergence of ﬂuoroquinolone
resistance in studied organisms. Clinical trials of
the 750mgms dose form have been undertaken
in complicated skin and skin structure infections,
nosocomial pneumonia, and febrile neutropenia;
results were at least comparable to standard, in-
tensively administered comparator agents. Use of
the same dose in community-acquired pneumonia
has allowed for more rapid resolution of symptoms
and a shortening of the course from ten to ﬁve
days. Dosing in healthy volunteers has been taken
as high as 1500mgms per day, without signiﬁcant
alteration of the adverse events proﬁle. Clinical
trial data show that the safety and tolerability of
750mgms daily are similar to those of the 250 and
500mgms forms.
CONCLUSION: Levoﬂoxacin has amply documented
efﬁcacy and safety credentials at clinical doses of
at least 750mgms once daily. Its higher target tis-
sue levels and broader microbiologic reach at that
drug exposure make it an attractive candidate for
monotherapy of some infections in the immunocom-
promised host or for combination therapy with such
other agents as the carbapenems or 4th generation
cephalosporins. Additional clinical trials using these
approaches seem warranted by the experience to
date.
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TRANSCRIPTIONAL ANALYSIS OF PURIFIED CIR-
CULATING T CELLS FROM TRAUMA PATIENTS RE-
VEALS UNIQUE GENE INTERACTIONS UNDETECTED
IN ANALYSIS OF WHOLE LEUKOCYTES
Miller-Graziano C*, Laudanski K, Xiao W. and the In-
ﬂammation and the Host Response to Injury Collab-
orative Program, www.gluegrant.org, USA
Variation in the composition of trauma patients’
circulating leukocyte subpopulation over time post
injury (PMN increased, T cells decreased) may af-
fect detection of cell speciﬁc gene expression. Con-
sequently, unique post-traumatic gene expression
might be revealed if microarray analysis were per-
formed on puriﬁed T cells or MO, as well as on total
circulating blood leukocytes.
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METHODS: Trauma-activated genes from 5 trauma
Pts with multiple organ failure and 5 matched
controls (Con) were compared using Affymetrix
microarray analysis (U133A GeneChip®) in various
cell populations: (1) total leukocytes (erythrocyte
lysed = LYSIS prep); (2) enriched MO or T cells
(commercial RosetteSepTM); (3) further puriﬁed
MO or T cells (Miltenyi column). The microarray
analysis included software, which displayed gene
expression changes as altered gene interactions.
Flow cytometry was performed to phenotype each
cell population using T cell markers (CD2, CD3), MO
markers (CD14, CD33), and markers for NK (CD56),
PMN (CD66b), and B cells (CD19). Mean and St Dev
were compared for Pts and controls.
RESULTS: The LYSIS prep had increased PMN (80% Pts
vs. 58% Con) but fewer T cells (7% vs. 29%). 432 (49↑,
383↓) genes were detected as uniquely altered in
Pt LYSIS prep. An additional 678 (60↑, 618↓) altered
genes were uniquely detected in isolated Pt MO and
1573 (1082↑, 491↓) in their isolated T cells. Some
gene alterations in the Pt LYSIS reﬂected not altered
T cell gene expression, but T cell depletion, as these
same genes were unchanged in parallel isolated Pt
T cells. Expression of several novel apoptotic and
regulatory genes was increased in isolated Pt T cells
but decreased or unchanged in MO and LYSIS.
CONCLUSIONS: Transcriptional analysis of Pt cir-
culating whole leukocyte population detected
trauma-activated genes, but additional biologically
relevant gene expression was revealed in leukocyte
subpopulations. Possibly novel apoptotic and regu-
latory T cell gene interactions were also revealed.
(Supported by NIH grant U54 GM62119)
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STUDY OF MICROBIAL BIOFILM WITH SPECIAL REF-
ERENCE TO CANDIDA INFECTION
Ravinder K*, Poonam G, Sharma VK, Sehga lR;
Maulana Azad Medical College and Lok Nayak Hos-
pital
Advances in medical and surgical therapies over
the last two decades have led to an increasing
number of immunocompromised individuals who
need extensive care in specialised units like Inten-
sive Care Units and are exposed to an increasing
number of bacterial and fungal infections, many of
which are centered on implanted devices used in
them.
OBJECTIVES: To study the spectrum of microbial
ﬂora of the luminal bioﬁlm associated with endotra-
cheal tubes/intravenous cathetors in ICU patients
with special reference to Candida. -To study the
pathogenecity of Candida spp. -To attempt to char-
acterise and type the Candida albicans strains.
METHODS: 91 indwelling device samples were col-
lected from 75 general medical/postop patients ad-
mitted to ICU of Lok Nayak hospital for more than
48 hours and processed for microscopy (light and
electron) and qualitative and quantitative cultures.
Duplicate blood samples and other relevant sam-
ples were also collected and processed. Bacterial
and fungal isolates ewre identiﬁed. Candida isolates
were tested for virulence properties by adherence
assay and were also typed by morphotyping and re-
sistotyping.
RESULTS & CONCLUSIONS: The patients belonged to
a wide age group of 0—75 years with male:female
ratio of 1.8:1.The most common risk factors for
ICU infections was presence of indwelling device
(100%) followed by duration of stay of more than
1 week (96%) and smoking (32%). Medical condi-
tion was the most frequent underlying condition
followed by trauma and surgical condition. Bioﬁlm
was demonstrated in 80 indwelling devices. Blood-
stream infectionwas seen in 18 cases (24%) followed
by UTI in 15 cases (20%). E. Coli was the commonest
bacterial isolate while Candida albicans and Can-
dida tropicaliswere the commonest fungal isolates.
Virulence markers in Candida spp. were seen to cor-
relate well with their pathogenic potential and the
typing procedures used in combination were found
to be highly useful.
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CARBAPENEM RESISTANCE MECHANISMS IN ICU
ISOLATES FROM TWO KUWAITI HOSPITALS
West PWJ1*, Dashti AA1, Denny BJ1, Johny M2;
1Kuwait University and 2Amiri Hospital, Kuwait
OBJECTIVE: To characterize the mechanisms re-
sponsible for reduced susceptibility to carbapen-
ems in bacterial isolates from intensive care unit
(ICU) patients admitted to the Amiri and Farwaniya
Hospitals, Kuwait.
METHODS: Bacterial isolates from ICU patients
were identiﬁed using the Vitek and API 20E and NE
system. Reduced carbapenem susceptibility was
detected using the Vitek system and/or Kirby-Bauer
method. Organisms were screened for metallo and
serine beta-lactamases using inhibitors including
EDTA, mercaptopropionic acid and clavulanate.
Permeability studies were conducted using outer
membrane permeabilizers including trisodium cit-
rate and sodium polyphosphate. Isoelectric focus-
ing studies were carried out in polyacrylamide gels
and the enzymes detected with nitroceﬁn.
RESULTS: Strains showing carbapenem minimum
inhibitory concentrations (MIC) of ≥4mg/L were
further investigated. These included Acineto-
bacter baumannii, Pseudomonas aeruginosa and
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Stenotrophomonas maltophilia isolates. Metallo
-enzymes were found in P. aeruginosa and S. mal-
tophilia. The P. aeruginosa enzyme was similar
to IMP-1 and the S. maltophilia enzyme to L-1.
A.baumannii isolates contain a serine enzyme sim-
ilar to OXA-25 and 26. Reduced permeability to
carbapenems was found in Paeruginosa and A. bau-
mannii. We have not found carbapenem resistance
in Enterobacteriaceae.
CONCLUSIONS: Carbapenem resistance has been
found in isolates from ICU patients in Kuwait.
Several resistance mechanisms have been de-
tected. Metallo-beta-lactamases are responsible
for high level resistance (MIC ≥ 16mg/L). Serine
beta-lactamases or reduced permeability, are re-
sponsible for low level resistance (MIC 4—8mg/L).
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PHYSIOLOGICAL IMPACT OF CICLOSPORIN A AND
A NON-IMMUNOSUPPRESSIVE ANALOGUE OF CI-
CLOSPORIN A IN A MURINE MODEL OF SEPSIS:
DIRECT MITOCHONDRIAL PROTECTION RATHER
THAN ANTI-APOPTOTIC EFFECT?
Larché J*, Lancel S, Nevière R; Departement de
Physiologie, Faculté de Médecine 1, place de Ver-
dun Lille Cedex 59045 France
OBJECTIVE: To study the effects of ciclosporin A
(CsA) and NIM 811, a non-immunosuppressive ana-
logue of CsA, on pro-apoptotic pathways in a murine
model of severe sepsis by caecal ligation and punc-
ture (CLP).
METHODS: C57BL6 mices were submitted to CLP
with a 21-G needle. 48 h-survival studies, detection
of oligonucleosomes (at 6 h, 14 h, and 36 h post-CLP)
and assessment of caspases 3 and 9 activation
(at 14 h) were performed in the following groups:
sham-operated, CLP, CLP + CsA, and CLP + NIM
811. CsA or NIM 811 was administered subcuta-
neously immediately after the surgical procedure.
RESULTS: Compared with CLP, CsA (2 and 10mg/kg)
improved 48 h-survival in CLP mices (respectively
32% vs. 100% and 60%; p < 0.05). NIM 811 (2mg/kg)
dramatically improved survival in CLP mice (100%
vs. 32%; p < 0.05). Compared with sham, heart nu-
clear apoptosis assessed by detection of oligonucle-
osomes was increased at 14 h post-CLP (p < 0.05),
which was prevented in CsA (2mg/kg) but not in
NIM 811 treated CLPmices. No signiﬁcant difference
was observed between sham, CLP, and CsA groups
for caspases 3 and 9 activation levels at 14 h-post
CLP.
CONCLUSIONS: Signiﬁcant improvement of 48 h-
survival was obtained with CsA and NIM 811 in a
clinically relevant model of severe sepsis. The ben-
eﬁcial impact of NIM 811 on survival excludes a
calcineurin-dependent mechanism in this model.
Low heart nuclear apoptosis in this CLP model is
transient, and its low intensity is likely insufﬁcient
to explain improved survival rate with inhibitors of
mitochondrial permeability transition pore.
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RESPIRATORY VIRUS INFECTIONS IN INTENSIVE
CARE UNIT PATIENTS IN SÃO PAULO, BRAZIL
Silva AR, Park M, Costa SF, Machado CM*; Virol-
ogy Laboratory, Instituto de Medicina Tropical de
São Paulo and ICU of the Department of Medicine,
University of São Paulo Medical School, São Paulo,
Brazil
OBJECTIVES: Evaluate the prevalence of respira-
tory virus (RV) infections (RSV, adenovirus, inﬂuenza
virus and parainﬂuenza) in patients admitted to the
ICU of the Department of Internal Medicine, evalu-
ate the impact of RV infections in the morbidity and
mortality of these patients, and evaluate the ratio
of these infections that are of nosocomial origin.
METHODS: Nasopharyngeal washes (NW) were taken
twice a week from 174 adult patients admitted
to the University Hospital ICU from May 2003 to
March 2004. Samples were analyzed by direct im-
munoﬂuorescence assay (DFA) (Imagen®, DAKO,
UK).
RESULTS: 410 samples were taken from 174 patients
irrespective of the presence of respiratory symp-
toms. The median age of the study population was
55 (16—92) years and 50.6% of the patients were
male. Seven patients (0.04%) tested positive by DFA
during the study period (6 inﬂuenza A and 1 parain-
ﬂuenza infection). The interval between hospital
and ICU admission and the length of the ICU stay
were greater among patients with positive results
(13.71× 7.26 days and 14× 10, 34 days, respec-
tively). Three patients (3/7) had positive results
15, 25 and 29 days after of hospital admission and
the remaining four tested positive up to 4 days af-
ter hospital admission (1, 1, 2 and 4 days). Pa-
tients with diabetes mellitus were more likely to
acquire RV infection as compared to non-diabetes
patients (71.4%, p = 0.02). The presence of other
co-morbid diseases (cardiac disease, arterial hyper-
tension, cerebral vascular disease, COPD/asthma,
cancer, renal failure, bone marrow transplant, solid
organ transplant, rheumatologic diseases and AIDS)
or the APACHE, use of mechanical ventilation, evo-
lution to septic shock or dead were similar between
RV infected and non-infected patients.
CONCLUSIONS: The prevalence of respiratory
viruses infection in ICU patients was 0.04% in this
series. Three of the seven RV infections (42.8%)
were considered of nosocomial origin.
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MONITORING OF CANDIDA SPP. IN SURGICAL ICU IN
CANCER HOSPITAL FOR 115 MONTHS
Petukhova IN*, Dmitrieva NV; Memorial N.N. Blokhin
Cancer Research Center, Moscow, Russia
OBJECTIVE: To study pattern and isolation rate of
Candida spp. in surgical ICU.
METHODS: Candida spp. isolated from various
pathologic materials from cancer patients admit-
ted in IX—2002—XI—2003 in ICU after extensive and
combined operations for esophageal cancer, gas-
tric cancer, colorectal cancer etc. were analyzed.
Selective medium ‘‘Chromagar’’ (Bio-Rad) and au-
tomatic analyzer ‘‘ATB-Expression’’ (Bio-Merrieuz.
France) were used for identiﬁcation.
RESULTS: 626 bacterial and fungal strains for 817
pathologic materials were isolated, including 121
strains of Candida spp. (19.3%), C. albicans was the
predominant strain that was isolated in 58 of 121
cases (47.9%). Two strains of Candida non-albicans
were isolated from blood in patients in septic pa-
tients in whom the same species was isolated from
more than one other loci. Wounds were infected
with mixed micro ﬂora including Candida spp. in pa-
tients who have previously received 2 or 3 lines of
antimicrobial therapy and all patients had Candida
non-albicans from wound discharge/drains. Twenty
eight C. albicans and 16 Candida non-albicans were
isolated from sputum and 26 C. albicans and 27
C. non-albicans were isolated from bronchoscopic
materials (brushes) in patients with clinical and
radiographic evidence of pneumonia. Prevalence
of C. albicans in sputum may be explained as
this material was taken from less severely ill pa-
tients, than bronchoscopy, which was undertaken
in critically ill patients. Urine was colonized for 4
C. albicans, and 13 Candida non-albicans. All pa-
tients had urinary catheters and did not have clin-
ical evidences of urinary infection. Non-albicans
Candida consisted of C. glabrata—30 (24.8%),
C. parapsilosis—13 (10.8%), C. krusei—6 (5%), C.
inconspicua/norbegensis—5 (4.1%), C. tropicalis—3
(2.5%), C. kefyr—2 (1.7%), C. Globosa, C. sake, C.
lusitaniae, C. dubliniensis—1 strain each (0.8%).
CONCLUSION: ICU patients often suffer from se-
vere infectious complications and are treated with
broad spectrum antibiotics, resulting in fungal col-
onization and super infections. The cause Candida
non-albicans colonization and infections may be ex-
tensive and inappropriate prophylactic use of ﬂu-
conazole.
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FUNGAL INFECTIONS IN ICU PATIENTS
Mukonde F*; UNZA-School of Medicine
OBJECTIVE: to document fungal infection in pa-
tients admitted to the ICU in the University Teach-
ing Hospital (UTH).
METHODS: This was a retrospective study of ICU
patient records from January 1—December 2002.
The study population was 518. Data analysis was
done using Epi info version 6. The Fishers test-2
tail probability was used to determine associa-
tions between factors when expected frequency
was less than 5. Otherwise the Chi-squared test
was used to determine association between fac-
tors. A result yielding a p value of more than
ﬁve percent was considered statistically insigniﬁ-
cant.
RESULTS: The median age (Q1, Q3) of the patients
was 31 (22,46) years and 56% of them were males.
Fungal infections, namely cryptococcal meningi-
tis was found in 2 (0.39%) patients. Other infec-
tions included bacterial meningitis 10 (1.93%),
HIV 2 (0.39%), pneumonia 7 (1.35%), tuberculo-
sis 8 (1.54%), tetanus 14 (2.70%), Guillain-Barre
Syndrome (GBS) 3 (0.58%), septicemia 8 (1.54%)
and HIV/GBS 1(0.19%). There was no associa-
tion between invasive procedure and outcome
(p = 0.53) at 95% conﬁdence level. There was 18%
risk of acquiring infection from invasive procedure
(RR = 1.18, 0.78 < RR < 1.79).
CONCLUSION: Fungal infection in ICU patients
was cryptococcal meningitis. There is minimal
risk of acquiring infection from invasive proce-
dure. Therefore blood cultures must be manda-
tory in all patients admitted to ICU to reduce this
risk.
